Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.

We observed an increase in OAA prevalence and the cost of oral targeted chemotherapy is high. Our findings underline the need for addressing these high-cost medications in future developments of a national drug program.